Tenaya Therapeutics Statistics
 Total Valuation
 TNYA has a market cap or net worth of $205.35 million. The enterprise value is $145.89 million.
 Important Dates
 The next estimated earnings date is Thursday, November 6, 2025, after market close.
 | Earnings Date | Nov 6, 2025 | 
| Ex-Dividend Date | n/a | 
Share Statistics
 TNYA has 162.98 million shares outstanding. The number of shares has increased by 41.30% in one year.
 | Current Share Class | 162.98M | 
| Shares Outstanding | 162.98M | 
| Shares Change (YoY) | +41.30% | 
| Shares Change (QoQ) | +48.17% | 
| Owned by Insiders (%) | 0.66% | 
| Owned by Institutions (%) | 16.34% | 
| Float | 152.50M | 
Valuation Ratios
  | PE Ratio | n/a | 
| Forward PE | n/a | 
| PS Ratio | n/a | 
| Forward PS | n/a | 
| PB Ratio | 2.06 | 
| P/TBV Ratio | 2.06 | 
| P/FCF Ratio | n/a | 
| P/OCF Ratio | n/a | 
| PEG Ratio | n/a | 
 Financial Ratio HistoryEnterprise Valuation
  | EV / Earnings | n/a | 
| EV / Sales | n/a | 
| EV / EBITDA | n/a | 
| EV / EBIT | n/a | 
| EV / FCF | n/a | 
Financial Position
 The company has a current ratio of 6.00, with a Debt / Equity ratio of 0.12.
 | Current Ratio | 6.00 | 
| Quick Ratio | 5.66 | 
| Debt / Equity | 0.12 | 
| Debt / EBITDA | n/a | 
| Debt / FCF | n/a | 
| Interest Coverage | n/a | 
Financial Efficiency
 Return on equity (ROE) is -85.21% and return on invested capital (ROIC) is -49.21%.
 | Return on Equity (ROE) | -85.21% | 
| Return on Assets (ROA) | -45.11% | 
| Return on Invested Capital (ROIC) | -49.21% | 
| Return on Capital Employed (ROCE) | -94.05% | 
| Revenue Per Employee | n/a | 
| Profits Per Employee | -$1.03M | 
| Employee Count | 97 | 
| Asset Turnover | n/a | 
| Inventory Turnover | n/a | 
Taxes
  | Income Tax | n/a | 
| Effective Tax Rate | n/a | 
Stock Price Statistics
 The stock price has decreased by -35.71% in the last 52 weeks. The beta is 3.16, so TNYA's price volatility has been higher than the market average.
 | Beta (5Y) | 3.16 | 
| 52-Week Price Change | -35.71% | 
| 50-Day Moving Average | 1.50 | 
| 200-Day Moving Average | 0.91 | 
| Relative Strength Index (RSI) | 33.28 | 
| Average Volume (20 Days) | 5,071,415 | 
Short Selling Information
 The latest short interest is 20.01 million, so 12.28% of the outstanding shares have been sold short.
 | Short Interest | 20.01M | 
| Short Previous Month | 14.98M | 
| Short % of Shares Out | 12.28% | 
| Short % of Float | 13.12% | 
| Short Ratio (days to cover) | 4.60 | 
Income Statement
  | Revenue | n/a | 
| Gross Profit | n/a | 
| Operating Income | -102.98M | 
| Pretax Income | -99.62M | 
| Net Income | -99.62M | 
| EBITDA | -94.05M | 
| EBIT | -102.98M | 
| Earnings Per Share (EPS) | -$0.89 | 
 Full Income StatementBalance Sheet
 The company has $71.67 million in cash and $12.21 million in debt, giving a net cash position of $59.46 million or $0.36 per share.
 | Cash & Cash Equivalents | 71.67M | 
| Total Debt | 12.21M | 
| Net Cash | 59.46M | 
| Net Cash Per Share | $0.36 | 
| Equity (Book Value) | 99.83M | 
| Book Value Per Share | 0.61 | 
| Working Capital | 63.22M | 
 Full Balance SheetCash Flow
 In the last 12 months, operating cash flow was -$76.95 million and capital expenditures -$913,000, giving a free cash flow of -$77.86 million.
 | Operating Cash Flow | -76.95M | 
| Capital Expenditures | -913,000 | 
| Free Cash Flow | -77.86M | 
| FCF Per Share | -$0.48 | 
 Full Cash Flow StatementMargins
  | Gross Margin | n/a | 
| Operating Margin | n/a | 
| Pretax Margin | n/a | 
| Profit Margin | n/a | 
| EBITDA Margin | n/a | 
| EBIT Margin | n/a | 
| FCF Margin | n/a | 
Dividends & Yields
 TNYA does not appear to pay any dividends at this time.
 | Dividend Per Share | n/a | 
| Dividend Yield | n/a | 
| Dividend Growth (YoY) | n/a | 
| Years of Dividend Growth | n/a | 
| Payout Ratio | n/a | 
| Buyback Yield | -41.30% | 
| Shareholder Yield | -41.30% | 
| Earnings Yield | -48.51% | 
| FCF Yield | -37.92% | 
 Analyst Forecast
 The average price target for TNYA is $8.60, which is 582.54% higher than the current price. The consensus rating is "Strong Buy".
 | Price Target | $8.60 | 
| Price Target Difference | 582.54% | 
| Analyst Consensus | Strong Buy | 
| Analyst Count | 5 | 
| Revenue Growth Forecast (5Y) | n/a | 
| EPS Growth Forecast (5Y) | n/a | 
 Stock ForecastsFair Value
 There are several formulas that can be used to estimate the intrinsic value of a stock.
 | Lynch Fair Value | n/a | 
| Lynch Upside | n/a | 
| Graham Number | n/a | 
| Graham Upside | n/a | 
Stock Splits
 This stock does not have any record of stock splits.
 | Last Split Date | n/a | 
| Split Type | n/a | 
| Split Ratio | n/a | 
Scores
  | Altman Z-Score | n/a | 
| Piotroski F-Score | 1 |